Genmab A/S (GMAB)
28.00
-1.34
(-4.57%)
USD |
NASDAQ |
May 24, 16:00
28.00
0.00 (0.00%)
After-Hours: 20:00
Genmab Cash from Investing (TTM): -394.15M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -394.15M |
| December 31, 2023 | -186.13M |
| September 30, 2023 | -158.69M |
| June 30, 2023 | -483.55M |
| March 31, 2023 | -292.66M |
| December 31, 2022 | -391.40M |
| September 30, 2022 | -404.45M |
| June 30, 2022 | -487.42M |
| March 31, 2022 | -159.67M |
| December 31, 2021 | -152.92M |
| September 30, 2021 | -206.90M |
| June 30, 2021 | -340.72M |
| March 31, 2021 | -455.41M |
| December 31, 2020 | -360.22M |
| September 30, 2020 | -430.56M |
| June 30, 2020 | -42.04M |
| March 31, 2020 | -293.88M |
| December 31, 2019 | -297.34M |
| September 30, 2019 | -218.29M |
| June 30, 2019 | -273.84M |
| March 31, 2019 | -171.14M |
| December 31, 2018 | -281.65M |
| September 30, 2018 | -179.29M |
| June 30, 2018 | -121.34M |
| March 31, 2018 | -158.85M |
| Date | Value |
|---|---|
| December 31, 2017 | -101.68M |
| September 30, 2017 | -180.31M |
| June 30, 2017 | -180.98M |
| March 31, 2017 | -170.07M |
| December 31, 2016 | -150.80M |
| September 30, 2016 | -82.15M |
| June 30, 2016 | -84.73M |
| March 31, 2016 | -58.01M |
| December 31, 2015 | -71.54M |
| September 30, 2015 | -61.29M |
| June 30, 2015 | -93.89M |
| March 31, 2015 | -142.90M |
| December 31, 2014 | -180.26M |
| September 30, 2014 | -175.34M |
| June 30, 2014 | -156.29M |
| March 31, 2014 | -96.54M |
| December 31, 2013 | 11.92M |
| September 30, 2013 | -116.29M |
| June 30, 2013 | -89.92M |
| March 31, 2013 | -72.73M |
| December 31, 2012 | -71.90M |
| September 30, 2012 | 44.20M |
| June 30, 2012 | 70.56M |
| March 31, 2012 | 84.01M |
| December 31, 2011 | 96.16M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-487.42M
Minimum
Jun 2022
-42.04M
Maximum
Jun 2020
-301.51M
Average
-295.61M
Median
Cash from Investing (TTM) Benchmarks
| Ascendis Pharma A/S | 91.67M |
| Novo Nordisk A/S | -4.838B |
| Galecto Inc | 26.61M |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | -0.186M |